戈谢病伴脊柱畸形一例并文献复习
A Case of Gaucher Disease Accompanied with the Spinal Deformity and Literature Review
DOI: 10.12677/ACM.2021.118512, PDF,   
作者: 步晓洁*:青岛大学,山东 青岛 ;赵艳霞#, 孙立荣:青岛大学附属医院儿童血液肿瘤科,山东 青岛
关键词: 戈谢病脊柱畸形生长发育酶替代治疗Gaucher Disease Spinal Deformity Growth and Development Enzyme Replacement Therapy
摘要: 目的:回顾性分析1例伴脊柱畸形的儿童戈谢病患者的临床资料,并查阅、复习相关文献,旨在提高临床医师对戈谢病骨骼损害的认识。方法:回顾性分析青岛大学附属医院儿童血液肿瘤科收治的1例伴脊柱畸形的儿童戈谢病患者的临床资料,并查阅相关文献进行总结分析,提高对戈谢病骨骼并发症的认识。结果:本研究中该患儿存在脊柱畸形且伴有膝关节疼痛的症状。磁共振检查结果提示股骨远端存在典型的烧瓶样改变,骨损害情况严重。经酶替代治疗后膝关节疼痛症状减轻,磁共振检查结果提示骨损害程度未见进一步加重。结论:确诊戈谢病之后及早进行酶替代治疗是治疗戈谢病的关键,可预防骨骼并发症或避免骨骼损害程度进一步加重。
Abstract: Objective: To review and analyse the clinical data of a case of gaucher disease in children with spine deformity, seeking and reviewing related literatures in order to improve the understanding of the bone lesion complications of gaucher disease in doctors. Methods: To review and analyse the clinical data of a case of gaucher disease in children with spine deformity, which was admitted to the Pediatric Hematology-Oncology Department of the Affiliated Hospital of Qingdao University, seeking and reviewing related literatures to make a summary, improving the understanding of the bone lesion of gaucher disease in doctors. Results: The child has the spine deformity and the symptoms of knee joint pain. MRI showed typical changes in the distal femur. It seems like the flask. The bone damage is serious. After receiving the enzyme replacement treatment, the pain of the knee joint was relieved and MRI showed that the bone damage is not further aggravated. Conclusion: After the diagnosis of gaucher disease, early enzyme replacement therapy is the key to the treatment of gaucher disease, it can prevent the bone complications and avoid the further development of bone damage.
文章引用:步晓洁, 赵艳霞, 孙立荣. 戈谢病伴脊柱畸形一例并文献复习[J]. 临床医学进展, 2021, 11(8): 3511-3516. https://doi.org/10.12677/ACM.2021.118512

参考文献

[1] Nalysnyk, L., Rotella, P., Simeone, J.C., et al. (2017) Gaucher Disease Epidemiology and Natural History: A Comprehensive Review of the Literature. Hematology, 22, 65-73. [Google Scholar] [CrossRef] [PubMed]
[2] Zion, Y.C., Pappadopulos, E., Wajnrajch, M., et al. (2016) Re-Thinking Fatigue in Gaucher Disease. Orphanet Journal of Rare Diseases, 29, 1-7.
[3] 商春阳, 陈春雷, 贾敦茂, 等. 戈谢病治疗方式研究进展[J]. 中华普通外科杂志, 2018, 33(5): 442-444.
[4] Masi, L. and Brandi, M.L. (2015) Gaucher Disease: The Role of the Specialist on Metabolic Bone Diseases. Clinical Cases in Mineral and Bone Metabolism, 12, 165-169. [Google Scholar] [CrossRef] [PubMed]
[5] Casirati, G., Baldini, M., Ulivieri, F.M., et al. (2018) Skeletal Involvement in Type 1 Gaucher Disease: Not Just Bone Mineral Density. Blood Cells, Molecules and Diseases, 68, 148-152. [Google Scholar] [CrossRef] [PubMed]
[6] Marcucci, G., Zimran, A., Bembi, B., et al. (2014) Gaucher Disease and Bone Manifestations. Calcified Tissue International, 95, 477-494. [Google Scholar] [CrossRef] [PubMed]
[7] Kaluzna, M., Trzeciak, I., Ziemnicka, K., et al. (2019) Endocrine and Metabolic Disorders in Patients with Gaucher Disease Type 1: A Review. Orphanet Journal of Rare Diseases, 14, 275. [Google Scholar] [CrossRef] [PubMed]
[8] Biegstraaten, M., Cox, T.M., Belmatoug, N., et al. (2016) Management Goals for Type 1 Gaucher Disease: An Expert Consensus Document from the European Working Group on Gaucher Disease. Blood Cells, Molecules and Diseases, 68, 203-208. [Google Scholar] [CrossRef] [PubMed]
[9] Yang, A.C., Bier, L., Overbey, J.R., et al. (2017) Early Manifestations of Type 1 Gaucher Disease in Presymptomatic Children Diagnosed after Parental Carrier Screening. Genetics in Medicine, 19, 652-658. [Google Scholar] [CrossRef] [PubMed]
[10] Giraldo, P., Pérez-López, J., Núňez, R., et al. (2016) Patients with Type 1 Gaucher Disease in Spain: A Cross-Sectional Evaluation of Health Status. Blood Cells, Molecules and Diseases, 56, 23-30. [Google Scholar] [CrossRef] [PubMed]
[11] Hughes, D., Mikosch, P., Belmatoug, N., et al. (2019) Gaucher Disease in Bone: From Pathophysiology to Practice. Journal of Bone and Mineral Research, 34, 996-1013. [Google Scholar] [CrossRef] [PubMed]
[12] Khan, A., Hangartner, T., Weinreb, N.J., et al. (2012) Risk Factors for Fractures and Avascular Osteonecrosis in Type 1 Gaucher Disease: A Study from the International Collaborative Gaucher Group (ICGG) Gaucher Registry. Journal of Bone and Mineral Research, 27, 1839-1848. [Google Scholar] [CrossRef] [PubMed]
[13] 曹隽, 张学军. 儿童早发性脊柱侧弯的系统治疗[J]. 临床小儿外科杂志, 2021, 20(1): 1-5.
[14] Revel-Vilk, S., Szer, J., Mehta, A., et al. (2018) How We Manage Gaucher Disease in the Era of Choices. British Journal of Haematology, 182, 467-480. [Google Scholar] [CrossRef] [PubMed]
[15] 中华医学会儿科学分会遗传代谢内分泌学组, 中华医学会儿科学分会血液学组, 中华医学会血液学分会红细胞疾病(贫血)学组. 中国戈谢病诊治专家共识(2015) [J]. 中华儿科杂志, 2015, 53(4): 256-261.
[16] El-Beshlawy, A., Tylki-Szymanska, A., Vellodi, A., et al. (2017) Long-Term Hematological, Visceral, and Growth Outcomes in Children with Gaucher Disease Type 3 Treated with Imiglucerase in the International Collaborative Gaucher Group Gaucher Registry. Molecular Genetics and Metabolism, 120, 47-56. [Google Scholar] [CrossRef] [PubMed]